| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | AKAP6 DAB2IP MTA2 WIPI1 HDAC5 RB1 HIPK1 BIRC2 SFR1 PIAS1 GRIP1 HGS RBM14 CAMTA1 USP15 NUP153 GAB1 DNMT3B FOXP3 | 2.97e-05 | 1160 | 114 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | protein domain specific binding | DAB2IP DOCK4 HIF1A LILRA2 RB1 MAP4K3 ARHGAP17 CBL PIAS1 GRIP1 CCDC88A WIZ HGS PAK3 PAX3 TRAK2 | 3.72e-05 | 875 | 114 | 16 | GO:0019904 |
| GeneOntologyMolecularFunction | kinase binding | DAB2IP DOCK4 HIF1A HDAC5 RB1 ATG13 DUSP1 TRIM64 CEP192 CBL LYST MEF2A TRIM64B CCDC88A IKBKB TSACC | 1.23e-04 | 969 | 114 | 16 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | DAB2IP DOCK4 HIF1A HDAC5 ATG13 DUSP1 TRIM64 CEP192 CBL LYST MEF2A TRIM64B CCDC88A IKBKB TSACC | 1.33e-04 | 873 | 114 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | histone methyltransferase binding | 1.39e-04 | 18 | 114 | 3 | GO:1990226 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.40e-04 | 417 | 114 | 10 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.53e-04 | 140 | 114 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.72e-04 | 143 | 114 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.99e-04 | 147 | 114 | 6 | GO:0042826 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | AKAP6 DAB2IP MTA2 WIPI1 HDAC5 RB1 HIPK1 BIRC2 SFR1 PIAS1 GRIP1 HGS RBM14 CAMTA1 USP15 NUP153 GAB1 DNMT3B FOXP3 | 2.34e-04 | 1356 | 114 | 19 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | HIF1A ZEB1 HDAC5 ESR2 PPARD RFX7 PRDM4 MEF2A EBF2 ARNT HOXC10 WIZ ZNF335 DMRTA2 PAX3 EMX2 SMAD4 FOXP3 | 2.36e-04 | 1244 | 114 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | HIF1A ZEB1 HDAC5 ESR2 PPARD RFX7 PRDM4 MEF2A EBF2 ARNT HOXC10 WIZ ZNF335 DMRTA2 PAX3 EMX2 SMAD4 FOXP3 | 3.06e-04 | 1271 | 114 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.46e-04 | 229 | 114 | 7 | GO:0003714 | |
| GeneOntologyMolecularFunction | transcription factor binding | MTA2 HIF1A WIPI1 HDAC5 RB1 PPARD PIAS1 MEF2A ARNT WIZ PAX3 SMAD4 FOXP3 | 3.66e-04 | 753 | 114 | 13 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coregulator activity | MTA2 HDAC5 RB1 HIPK1 BIRC2 SFR1 PIAS1 RBM14 CAMTA1 DNMT3B FOXP3 | 3.74e-04 | 562 | 114 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MTA2 HIF1A WIPI1 HDAC5 RB1 PPARD PIAS1 MEF2A ARNT SMAD4 FOXP3 | 5.02e-04 | 582 | 114 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | HIF1A ZEB1 HDAC5 RB1 ESR2 PPARD RFX7 PRDM4 MEF2A EBF2 ARNT HOXC10 WIZ ZNF335 DMRTA2 PAX3 EMX2 SMAD4 FOXP3 | 5.82e-04 | 1459 | 114 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 5.94e-04 | 29 | 114 | 3 | GO:0035035 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 1.04e-03 | 78 | 114 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HIF1A ZEB1 HDAC5 ESR2 PPARD RFX7 PRDM4 MEF2A EBF2 ARNT HOXC10 WIZ YLPM1 DMRTA2 PAX3 EMX2 SMAD4 FOXP3 | 1.05e-03 | 1412 | 114 | 18 | GO:0000981 |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.11e-03 | 279 | 114 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor 2 binding | 1.41e-03 | 10 | 114 | 2 | GO:0043184 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 2.26e-03 | 316 | 114 | 7 | GO:0035091 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 2.60e-03 | 48 | 114 | 3 | GO:0032266 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 2.81e-03 | 14 | 114 | 2 | GO:0036312 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | DAB2IP MTA2 HIF1A ZEB1 SETX HDAC5 RB1 ESR2 AKNA TSC2 PPARD RFX7 PRDM4 MEF2A EBF2 ZNF462 ARNT HOXC10 ZNF335 RBM14 PAX3 CAMTA1 IKBKB SMAD4 FOXP3 | 1.02e-07 | 1390 | 113 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | DAB2IP MTA2 ROBO4 HIF1A HDAC5 LEMD3 TSC2 PPARD SEMA6D MEGF8 PAK3 PAX3 PLEC TNS1 GAB1 SMAD4 | 1.03e-07 | 577 | 113 | 16 | GO:0001667 |
| GeneOntologyBiologicalProcess | regulation of cell development | HIF1A LILRA2 ZEB1 HDAC5 RB1 TSC2 RYK TIAM2 GRIP1 ARNT SEMA6D MEGF8 ZNF335 PAK3 DMRTA2 TRAK2 IKBKB IL4R SMAD4 FOXP3 | 1.90e-06 | 1095 | 113 | 20 | GO:0060284 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 ROBO4 MYOT RB1 TRIOBP ALS2 TSC2 MEF2A RYK TIAM2 GRIP1 SEMA6D MEGF8 PAK3 TRAK2 SMAD4 | 3.18e-06 | 748 | 113 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP TANC2 ROBO4 SETX MYOT RB1 TRIOBP ALS2 TSC2 MEF2A RYK TIAM2 GRIP1 CCDC88A SEMA6D MEGF8 ZNF335 PAK3 TRAK2 IKBKB SMAD4 | 5.81e-06 | 1285 | 113 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DAB2IP TANC2 ROBO4 MYOT ALS2 TSC2 MEF2A RYK TIAM2 GRIP1 SEMA6D MEGF8 ZNF335 PAK3 TRAK2 SMAD4 | 7.69e-06 | 802 | 113 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DAB2IP TANC2 ROBO4 MYOT ALS2 TSC2 MEF2A RYK TIAM2 GRIP1 SEMA6D MEGF8 ZNF335 PAK3 TRAK2 SMAD4 | 9.99e-06 | 819 | 113 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DAB2IP TANC2 ROBO4 MYOT ALS2 TSC2 MEF2A RYK TIAM2 GRIP1 SEMA6D MEGF8 ZNF335 PAK3 TRAK2 SMAD4 | 1.11e-05 | 826 | 113 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron development | DAB2IP TANC2 ROBO4 TMEM67 SETX MYOT RB1 TRIOBP ALS2 TSC2 MEF2A RYK TIAM2 GRIP1 CCDC88A SEMA6D MEGF8 ZNF335 PAK3 TRAK2 IKBKB SMAD4 | 1.26e-05 | 1463 | 113 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | negative regulation of cell growth | 2.22e-05 | 212 | 113 | 8 | GO:0030308 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | DAB2IP TANC2 ROBO4 MYOT RB1 TRIOBP ALS2 TSC2 MEF2A RYK TIAM2 GRIP1 SEMA6D MEGF8 ZNF335 PAK3 TRAK2 PLEC SMAD4 | 2.50e-05 | 1194 | 113 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | HIF1A RB1 TSC2 RYK TIAM2 GRIP1 SEMA6D MEGF8 ZNF335 PAK3 DMRTA2 TRAK2 | 2.59e-05 | 515 | 113 | 12 | GO:0050767 |
| GeneOntologyBiologicalProcess | negative regulation of growth | 2.61e-05 | 283 | 113 | 9 | GO:0045926 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | DAB2IP TANC2 SETX TSC2 RYK TIAM2 GRIP1 CCDC88A SEMA6D MEGF8 PAK3 TRAK2 IKBKB | 3.09e-05 | 612 | 113 | 13 | GO:0010975 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | AKAP6 ZEB1 HDAC5 RB1 PIAS1 MEF2A TMTC3 TANC1 PAX3 PLEC IL4R SMAD4 | 3.50e-05 | 531 | 113 | 12 | GO:0042692 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 4.34e-05 | 233 | 113 | 8 | GO:0061351 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | AKAP6 DAB2IP HIF1A LILRA2 RB1 ATG13 DUSP1 BIRC2 ALS2 TSC2 CBL PIAS1 ARNT CCDC88A HGS UBXN2A PLEC CAMTA1 IKBKB TSACC GAB1 | 5.21e-05 | 1488 | 113 | 21 | GO:0031399 |
| GeneOntologyBiologicalProcess | fibroblast migration | 6.52e-05 | 77 | 113 | 5 | GO:0010761 | |
| GeneOntologyBiologicalProcess | muscle structure development | AKAP6 ZEB1 HDAC5 RB1 LEMD3 PPARD PIAS1 MEF2A TMTC3 DMRTA2 TANC1 PAX3 PLEC IL4R SMAD4 | 6.91e-05 | 858 | 113 | 15 | GO:0061061 |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 7.83e-05 | 80 | 113 | 5 | GO:2000179 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 9.13e-05 | 192 | 113 | 7 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of vascular endothelial growth factor receptor signaling pathway | 9.79e-05 | 44 | 113 | 4 | GO:0030947 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.00e-04 | 135 | 113 | 6 | GO:2000177 | |
| GeneOntologyBiologicalProcess | B cell homeostasis | 1.38e-04 | 48 | 113 | 4 | GO:0001782 | |
| GeneOntologyBiologicalProcess | pattern specification process | TMEM67 HIF1A ZEB1 HIPK1 RTTN HOXC10 MEGF8 DMRTA2 PAX3 EMX2 SMAD4 | 1.49e-04 | 526 | 113 | 11 | GO:0007389 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | AKAP6 HIF1A ZEB1 RB1 PPARD PIAS1 TIAM2 GRIP1 ARNT MEGF8 ZNF335 PAK3 DMRTA2 IL4R SMAD4 DNMT3B FOXP3 | 1.56e-04 | 1141 | 113 | 17 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | HIF1A RB1 TSC2 RYK TIAM2 GRIP1 SEMA6D MEGF8 ZNF335 PAK3 DMRTA2 TRAK2 | 1.64e-04 | 625 | 113 | 12 | GO:0051960 |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 1.86e-04 | 96 | 113 | 5 | GO:0035914 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | DAB2IP MTA2 HIF1A ZEB1 HDAC5 RB1 HIPK1 ESR2 PPARD PIAS1 MEF2A YLPM1 PAX3 SMAD4 DNMT3B FOXP3 | 1.99e-04 | 1053 | 113 | 16 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DAB2IP TANC2 TMEM67 SETX TSC2 RYK TIAM2 GRIP1 CCDC88A SEMA6D MEGF8 PAK3 TRAK2 IKBKB | 2.17e-04 | 846 | 113 | 14 | GO:0120035 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | DAB2IP HIF1A ZEB1 SETX LEMD3 ESR2 TSC2 CBL RYK ARNT CCDC88A MEGF8 HGS PAK3 USP15 GAB1 SMAD4 | 2.46e-04 | 1186 | 113 | 17 | GO:0007167 |
| GeneOntologyBiologicalProcess | heart development | AKAP6 TMEM67 HIF1A HDAC5 DSG2 RB1 TSC2 MEF2A MEGF8 PAX3 PLEC GAB1 SMAD4 | 2.59e-04 | 757 | 113 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DAB2IP TANC2 TMEM67 SETX TSC2 RYK TIAM2 GRIP1 CCDC88A SEMA6D MEGF8 PAK3 TRAK2 IKBKB | 2.66e-04 | 863 | 113 | 14 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | AKAP6 DAB2IP HIF1A HDAC5 RB1 HIPK1 ESR2 PKP4 ARHGAP17 ALS2 TSC2 AGAP11 RYK TIAM2 EBF2 CCDC88A IKBKB TSACC GAB1 | 2.71e-04 | 1430 | 113 | 19 | GO:0044093 |
| GeneOntologyBiologicalProcess | cell junction organization | DAB2IP TANC2 MYOT DSG2 HIPK1 PKP4 ALS2 TSC2 THSD1 RYK PAK3 TANC1 PLEC IKBKB TNS1 | 2.77e-04 | 974 | 113 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | axonogenesis | ROBO4 MYOT ALS2 TSC2 RYK TIAM2 SEMA6D MEGF8 PAK3 TRAK2 SMAD4 | 2.80e-04 | 566 | 113 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | DAB2IP TANC2 HIF1A HIPK1 MYO19 TSC2 RYK TIAM2 GRIP1 SEMA6D MEGF8 HGS PAK3 PAX3 TRAK2 GAB1 | 2.93e-04 | 1090 | 113 | 16 | GO:0022603 |
| GeneOntologyBiologicalProcess | regionalization | 3.00e-04 | 478 | 113 | 10 | GO:0003002 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 3.04e-04 | 391 | 113 | 9 | GO:0051146 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 3.73e-04 | 62 | 113 | 4 | GO:0050771 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone metabolic process | 3.80e-04 | 26 | 113 | 3 | GO:0032352 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | DAB2IP RB1 DUSP1 ALS2 TSC2 CBL RYK CCDC88A HGS PLEC TSACC GAB1 | 3.83e-04 | 686 | 113 | 12 | GO:0043549 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | DAB2IP TMEM67 SETX TSC2 TIAM2 GRIP1 CCDC88A MEGF8 PAK3 IKBKB | 3.89e-04 | 494 | 113 | 10 | GO:0031346 |
| GeneOntologyBiologicalProcess | mitochondrion localization | 3.97e-04 | 63 | 113 | 4 | GO:0051646 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | DAB2IP ROBO4 TMEM67 HIF1A ZEB1 HDAC5 LEMD3 HIPK1 TSC2 TMTC3 MEGF8 HGS PAX3 EMX2 GAB1 SMAD4 | 4.15e-04 | 1125 | 113 | 16 | GO:0035239 |
| GeneOntologyBiologicalProcess | mitochondrion distribution | 4.25e-04 | 27 | 113 | 3 | GO:0048311 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 5.33e-04 | 611 | 113 | 11 | GO:0045859 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 5.51e-04 | 338 | 113 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor receptor signaling pathway | 5.61e-04 | 69 | 113 | 4 | GO:0048010 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 5.72e-04 | 519 | 113 | 10 | GO:0001558 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | DOCK4 HIF1A ESR2 TRIOBP ALS2 TSC2 PPARD RYK SEMA6D MEGF8 PAK3 | 5.86e-04 | 618 | 113 | 11 | GO:0090066 |
| GeneOntologyBiologicalProcess | positive regulation of epidermal growth factor receptor signaling pathway | 6.44e-04 | 31 | 113 | 3 | GO:0045742 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | DAB2IP LILRA2 BIRC2 HMCES BMX RBM14 PAK3 PLA2G4A IKBKB USP15 IL4R FYB2 FOXP3 | 7.32e-04 | 845 | 113 | 13 | GO:0050778 |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 7.32e-04 | 353 | 113 | 8 | GO:0010721 | |
| GeneOntologyBiologicalProcess | placenta development | 7.62e-04 | 197 | 113 | 6 | GO:0001890 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | DAB2IP HIF1A ZEB1 SETX LEMD3 CBL GRIP1 ARNT MEGF8 HGS USP15 GAB1 SMAD4 | 7.72e-04 | 850 | 113 | 13 | GO:0071363 |
| GeneOntologyBiologicalProcess | positive regulation of ERBB signaling pathway | 7.75e-04 | 33 | 113 | 3 | GO:1901186 | |
| GeneOntologyBiologicalProcess | axon development | ROBO4 MYOT ALS2 TSC2 RYK TIAM2 SEMA6D MEGF8 PAK3 TRAK2 SMAD4 | 8.02e-04 | 642 | 113 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | DAB2IP HIF1A SETX ESR2 TSC2 CBL RYK ARNT CCDC88A HGS PAK3 GAB1 | 8.13e-04 | 747 | 113 | 12 | GO:0007169 |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta2 production | 8.15e-04 | 8 | 113 | 2 | GO:0032909 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta2 production | 8.15e-04 | 8 | 113 | 2 | GO:0032906 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | AKAP6 DAB2IP HIF1A LILRA2 HIPK1 DUSP1 BIRC2 SMPD4 CBL UBXN2A IKBKB IL4R GAB1 SMAD4 | 8.22e-04 | 967 | 113 | 14 | GO:0071345 |
| GeneOntologyBiologicalProcess | circulatory system development | AKAP6 DAB2IP ROBO4 TMEM67 HIF1A HDAC5 DSG2 RB1 LEMD3 HIPK1 TSC2 MEF2A MEGF8 HGS PAX3 PLEC GAB1 SMAD4 | 8.33e-04 | 1442 | 113 | 18 | GO:0072359 |
| GeneOntologyBiologicalProcess | response to cytokine | AKAP6 DAB2IP HIF1A LILRA2 MAP4K3 HIPK1 DUSP1 BIRC2 SMPD4 CBL UBXN2A IKBKB IL4R GAB1 SMAD4 | 8.36e-04 | 1083 | 113 | 15 | GO:0034097 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | 8.43e-04 | 546 | 113 | 10 | GO:0051656 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 8.95e-04 | 280 | 113 | 7 | GO:1902115 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | TMEM67 DUSP1 TRIOBP BIRC2 TSC2 CEP192 SNX33 RYK SEMA6D RBM14 TRAK2 IKBKB SMAD4 | 8.97e-04 | 864 | 113 | 13 | GO:0051129 |
| GeneOntologyBiologicalProcess | response to peptide | AKAP6 DAB2IP HIF1A LILRA2 MAP4K3 HIPK1 DUSP1 BIRC2 SMPD4 CBL UBXN2A IKBKB IL4R GAB1 SMAD4 | 9.78e-04 | 1100 | 113 | 15 | GO:1901652 |
| GeneOntologyBiologicalProcess | muscle tissue development | 9.94e-04 | 558 | 113 | 10 | GO:0060537 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TMEM67 HIF1A WIPI1 RB1 MYO19 DUSP1 TRIOBP ARHGAP17 TSC2 CEP192 CCDC88A YLPM1 SEC16A RBM14 PAK3 PLA2G4A SMAD4 | 1.00e-03 | 1342 | 113 | 17 | GO:0033043 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | DAB2IP LILRA2 ZEB1 HDAC5 RB1 TSC2 PPARD RYK SEMA6D TRAK2 IL4R SMAD4 FOXP3 | 1.01e-03 | 875 | 113 | 13 | GO:0045596 |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 1.01e-03 | 139 | 113 | 5 | GO:0007173 | |
| GeneOntologyBiologicalProcess | centrosome duplication | 1.03e-03 | 81 | 113 | 4 | GO:0051298 | |
| GeneOntologyBiologicalProcess | cerebral cortex regionalization | 1.04e-03 | 9 | 113 | 2 | GO:0021796 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta production | 1.09e-03 | 37 | 113 | 3 | GO:0071634 | |
| GeneOntologyBiologicalProcess | response to growth factor | DAB2IP HIF1A ZEB1 SETX LEMD3 CBL GRIP1 ARNT MEGF8 HGS USP15 GAB1 SMAD4 | 1.09e-03 | 883 | 113 | 13 | GO:0070848 |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 1.18e-03 | 84 | 113 | 4 | GO:0008333 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | DAB2IP LILRA2 RB1 BIRC2 LYST HMCES BMX ZNF335 RBM14 PAK3 PLA2G4A IKBKB USP15 IL4R FYB2 FOXP3 | 1.20e-03 | 1242 | 113 | 16 | GO:0002684 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DAB2IP TMEM67 HIF1A WIPI1 SETX RB1 TSC2 CBL TIAM2 GRIP1 CCDC88A MEGF8 PAK3 PLA2G4A IKBKB IL4R SMAD4 | 1.22e-03 | 1366 | 113 | 17 | GO:0051130 |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.23e-03 | 296 | 113 | 7 | GO:0048762 | |
| GeneOntologyBiologicalProcess | establishment of mitochondrion localization | 1.27e-03 | 39 | 113 | 3 | GO:0051654 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 1.28e-03 | 86 | 113 | 4 | GO:0042058 | |
| GeneOntologyCellularComponent | axon | DAB2IP TANC2 ROBO4 HIF1A SETX MYOT HDAC5 ALS2 TSC2 CBL TIAM2 GRIP1 TANC1 TRAK2 PLEC EMX2 | 3.32e-05 | 891 | 116 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | chromatin | MTA2 HIF1A ZEB1 HDAC5 RB1 ESR2 PPARD RFX7 SFR1 PIAS1 MEF2A EBF2 ARNT HOXC10 DMRTA2 PAX3 EMX2 SMAD4 DNMT3B FOXP3 | 1.76e-04 | 1480 | 116 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | centrosome | TMEM67 HIPK1 RTTN AKNA TRIOBP ALS2 CEP192 FIGN SFR1 CCDC88A TUBGCP3 IL4R SMAD4 | 3.48e-04 | 770 | 116 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | growth cone | 4.40e-04 | 245 | 116 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 5.33e-04 | 253 | 116 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | microtubule organizing center | TMEM67 HIPK1 RTTN AKNA TRIOBP CILK1 ALS2 CEP192 FIGN SFR1 CCDC88A TUBGCP3 IL4R SMAD4 | 5.72e-04 | 919 | 116 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | distal axon | 7.21e-04 | 435 | 116 | 9 | GO:0150034 | |
| MousePheno | embryonic lethality, incomplete penetrance | MTA2 HIF1A DSG2 ATG13 TSC2 PPARD HMCES GRIP1 PAX3 GAB1 SMAD4 DNMT3B | 1.88e-05 | 410 | 94 | 12 | MP:0011102 |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | MTA2 HIF1A DSG2 ATG13 TSC2 PPARD HMCES GRIP1 PAX3 GAB1 SMAD4 DNMT3B | 1.88e-05 | 410 | 94 | 12 | MP:0031660 |
| MousePheno | abnormal nervous system development | ROBO4 TMEM67 HIF1A ZEB1 RB1 HIPK1 RTTN CILK1 TSC2 FIGN SFR1 EBF2 GRIP1 ARNT CCDC88A MEGF8 HGS PAK3 DMRTA2 PAX3 EMX2 DNMT3B | 2.29e-05 | 1257 | 94 | 22 | MP:0003861 |
| MousePheno | abnormal pelvic girdle joint morphology | 2.40e-05 | 9 | 94 | 3 | MP:0030819 | |
| MousePheno | abnormal hip joint morphology | 2.40e-05 | 9 | 94 | 3 | MP:0030829 | |
| MousePheno | abnormal fluid regulation | ROBO4 HIF1A ZEB1 DSG2 RB1 DUSP1 ESR2 RTTN CILK1 RYK ZNF462 MEGF8 UBXN2A PLEC GAB1 DNMT3B FOXP3 | 3.16e-05 | 826 | 94 | 17 | MP:0001784 |
| MousePheno | prenatal lethality, incomplete penetrance | MTA2 HIF1A DSG2 RB1 ATG13 TSC2 PPARD FIGN CBL HMCES GRIP1 ARNT PAX3 GAB1 SMAD4 DNMT3B | 3.46e-05 | 747 | 94 | 16 | MP:0011101 |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | AKAP6 MTA2 TMEM67 ZEB1 RB1 AKNA TSC2 FIGN CBL PIAS1 MEF2A RYK EBF2 GRIP1 WIZ TMTC3 DMRTA2 PAX3 GAB1 DNMT3B | 4.64e-05 | 1124 | 94 | 20 | MP:0011112 |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 6.79e-05 | 263 | 94 | 9 | MP:0011099 | |
| MousePheno | effusion | 7.26e-05 | 152 | 94 | 7 | MP:0021205 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 7.85e-05 | 268 | 94 | 9 | MP:0011108 | |
| MousePheno | increased circulating interleukin-4 level | 8.02e-05 | 13 | 94 | 3 | MP:0008602 | |
| MousePheno | abnormal olfactory neuron innervation pattern | 8.02e-05 | 13 | 94 | 3 | MP:0012014 | |
| MousePheno | abnormal hindbrain size | 8.02e-05 | 13 | 94 | 3 | MP:0012262 | |
| MousePheno | abnormal girdle joint morphology | 1.02e-04 | 14 | 94 | 3 | MP:0030818 | |
| MousePheno | open neural tube | 1.39e-04 | 226 | 94 | 8 | MP:0000929 | |
| MousePheno | lethality throughout fetal growth and development | 1.58e-04 | 435 | 94 | 11 | MP:0006208 | |
| MousePheno | abnormal neurite morphology | DAB2IP DUSP1 WDR81 ALS2 TSC2 EBF2 CCDC88A HGS PAK3 TANC1 PLEC | 1.81e-04 | 442 | 94 | 11 | MP:0008415 |
| MousePheno | abnormal cerebellar cortex morphology | 1.84e-04 | 300 | 94 | 9 | MP:0004097 | |
| MousePheno | abnormal keratinocyte physiology | 2.11e-04 | 81 | 94 | 5 | MP:0003453 | |
| MousePheno | abnormal intercalated disk morphology | 2.23e-04 | 18 | 94 | 3 | MP:0006267 | |
| MousePheno | embryonic lethality during organogenesis | HIF1A DSG2 RB1 LEMD3 ATG13 RTTN TSC2 PPARD GRIP1 LIPT1 ARNT HGS PAX3 IKBKB GAB1 DNMT3B | 2.24e-04 | 876 | 94 | 16 | MP:0006207 |
| MousePheno | abnormal craniofacial morphology | AKAP6 MTA2 TMEM67 HIF1A ZEB1 RB1 CILK1 AGAP11 FIGN CBL LYST RYK EBF2 ARNT WIZ MEGF8 PAX3 EMX2 GAB1 DNMT3B FOXP3 | 2.49e-04 | 1372 | 94 | 21 | MP:0000428 |
| MousePheno | craniofacial phenotype | AKAP6 MTA2 TMEM67 HIF1A ZEB1 RB1 CILK1 AGAP11 FIGN CBL LYST RYK EBF2 ARNT WIZ MEGF8 PAX3 EMX2 GAB1 DNMT3B FOXP3 | 2.49e-04 | 1372 | 94 | 21 | MP:0005382 |
| MousePheno | abnormal hindlimb joint morphology | 3.09e-04 | 20 | 94 | 3 | MP:0030808 | |
| MousePheno | dilated brain ventricle | 3.83e-04 | 92 | 94 | 5 | MP:0012676 | |
| MousePheno | abnormal hindbrain morphology | 4.02e-04 | 485 | 94 | 11 | MP:0000841 | |
| MousePheno | abnormal head morphology | TMEM67 HIF1A ZEB1 RB1 CILK1 AGAP11 FIGN CBL LYST RYK EBF2 ARNT WIZ MEGF8 PAX3 GAB1 DNMT3B FOXP3 | 4.19e-04 | 1120 | 94 | 18 | MP:0000432 |
| MousePheno | small olfactory bulb | 4.36e-04 | 53 | 94 | 4 | MP:0002741 | |
| MousePheno | absent dentate gyrus | 4.42e-04 | 5 | 94 | 2 | MP:0000814 | |
| MousePheno | abnormal Purkinje cell morphology | 4.45e-04 | 204 | 94 | 7 | MP:0000877 | |
| MousePheno | abnormal T cell physiology | MTA2 LILRA2 MAP4K3 BIRC2 CBL LYST PLEC IKBKB USP15 IL4R DNMT3B FOXP3 | 5.27e-04 | 584 | 94 | 12 | MP:0002444 |
| MousePheno | abnormal skin morphology | MTA2 RB1 ESR2 RTTN TSC2 AGAP11 PPARD FIGN CBL LYST RYK EBF2 GRIP1 LIPT1 MEGF8 TANC1 PAX3 TRAK2 PLEC GAB1 FOXP3 | 5.51e-04 | 1455 | 94 | 21 | MP:0002060 |
| MousePheno | abnormal neural tube morphology | TMEM67 HIF1A ZEB1 HIPK1 RTTN TSC2 SFR1 GRIP1 ARNT HGS PAX3 DNMT3B | 5.86e-04 | 591 | 94 | 12 | MP:0002151 |
| MousePheno | embryonic lethality between implantation and somite formation, incomplete penetrance | 6.08e-04 | 25 | 94 | 3 | MP:0011106 | |
| MousePheno | abnormal limb joint morphology | 6.08e-04 | 25 | 94 | 3 | MP:0030805 | |
| MousePheno | abnormal leukopoiesis | LILRA2 ZEB1 RB1 MAP4K3 ESR2 ARHGAP17 CBL ZNF335 PLA2G4A IKBKB DNMT3B FOXP3 | 6.13e-04 | 594 | 94 | 12 | MP:0005460 |
| MousePheno | abnormal blood vessel morphology | DOCK4 ROBO4 TMEM67 HIF1A ZEB1 RB1 LEMD3 ESR2 SMPD4 TSC2 RYK EBF2 GRIP1 LIPT1 ARNT CCDC88A MEGF8 PAX3 GAB1 DNMT3B FOXP3 | 6.42e-04 | 1472 | 94 | 21 | MP:0001614 |
| MousePheno | alveolitis | 6.59e-04 | 6 | 94 | 2 | MP:0010922 | |
| MousePheno | abnormal lung bud morphology | 6.59e-04 | 6 | 94 | 2 | MP:0010906 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 6.98e-04 | 220 | 94 | 7 | MP:0000875 | |
| MousePheno | abnormal skin physiology | 7.08e-04 | 288 | 94 | 8 | MP:0005501 | |
| MousePheno | cleft palate | 7.24e-04 | 289 | 94 | 8 | MP:0000111 | |
| Domain | PH | 5.99e-05 | 278 | 116 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 6.16e-05 | 279 | 116 | 9 | PS50003 | |
| Domain | PH_domain | 6.33e-05 | 280 | 116 | 9 | IPR001849 | |
| Domain | PH_dom-like | DAB2IP PLEKHF2 TRIOBP ALS2 AGAP11 PLEKHA6 LYST TIAM2 BMX TNS1 GAB1 | 7.01e-05 | 426 | 116 | 11 | IPR011993 |
| Domain | - | DAB2IP PLEKHF2 TRIOBP ALS2 AGAP11 PLEKHA6 TIAM2 BMX TNS1 GAB1 | 1.64e-04 | 391 | 116 | 10 | 2.30.29.30 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK4 DSG2 LEMD3 PKP4 WDR81 ARHGAP17 ALS2 TIAM2 CCDC88A HGS PAK3 | 4.46e-05 | 450 | 80 | 11 | M27078 |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 5.51e-05 | 37 | 80 | 4 | MM14488 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 6.13e-05 | 38 | 80 | 4 | M495 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 6.15e-05 | 74 | 80 | 5 | M39857 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 9.07e-05 | 325 | 80 | 9 | M12868 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.59e-04 | 143 | 80 | 6 | M39591 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.68e-04 | 49 | 80 | 4 | MM15448 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK4 DSG2 LEMD3 MYO19 PKP4 WDR81 ARHGAP17 ALS2 TIAM2 CCDC88A HGS PAK3 TRAK2 | 1.91e-04 | 720 | 80 | 13 | M41838 |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 2.12e-04 | 52 | 80 | 4 | M2341 | |
| Pathway | WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES | 2.51e-04 | 22 | 80 | 3 | M39773 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.51e-04 | 22 | 80 | 3 | MM1443 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.87e-04 | 23 | 80 | 3 | M2821 | |
| Pathway | REACTOME_RHOT1_GTPASE_CYCLE | 3.15e-04 | 5 | 80 | 2 | M41820 | |
| Pathway | PID_FCER1_PATHWAY | 3.68e-04 | 60 | 80 | 4 | M7 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 4.70e-04 | 6 | 80 | 2 | MM14521 | |
| Pathway | WP_CANCER_PATHWAYS | 5.69e-04 | 507 | 80 | 10 | M48302 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 6.15e-04 | 184 | 80 | 6 | M41809 | |
| Pathway | WP_TH17_CELL_DIFFERENTIATION_PATHWAY | 6.28e-04 | 69 | 80 | 4 | M45541 | |
| Pathway | REACTOME_MIRO_GTPASE_CYCLE | 6.56e-04 | 7 | 80 | 2 | MM15689 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 6.56e-04 | 7 | 80 | 2 | MM15533 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 6.64e-04 | 70 | 80 | 4 | M13266 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 7.05e-04 | 31 | 80 | 3 | M48258 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 7.05e-04 | 31 | 80 | 3 | M27805 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 DOCK4 SETX DSG2 ATG13 ARHGAP17 ALS2 TSC2 CEP192 RFX7 CBL LYST GRIP1 BMX CCDC88A MEGF8 SEC16A RBM14 TANC1 USP54 PLEC GAB1 | 1.89e-13 | 861 | 119 | 22 | 36931259 |
| Pubmed | DAB2IP DOCK4 HDAC5 HIPK1 ATG13 ALS2 CEP192 IGDCC4 SEMA6D MEGF8 SEC16A CIPC TRAK2 CAMTA1 USP15 | 1.12e-11 | 407 | 119 | 15 | 12693553 | |
| Pubmed | DAB2IP DSG2 LEMD3 MAP4K3 TMEM51 PKP4 TRIOBP PLEKHA6 CBL GRIP1 CCDC88A SEMA6D HGS SEC16A GAB1 | 1.80e-11 | 421 | 119 | 15 | 36976175 | |
| Pubmed | SETX MAP4K3 HIPK1 DUSP1 ARHGAP17 PLEKHA6 CBL PIAS1 CCDC88A HGS PAK3 PLEC TNS1 NUP153 GAB1 | 1.34e-10 | 486 | 119 | 15 | 20936779 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 SETX HDAC5 RB1 HIPK1 ARHGAP17 CEP192 MORC4 PIAS1 ARNT CCDC88A SEC16A RBM14 TANC1 GAB1 | 1.82e-09 | 588 | 119 | 15 | 38580884 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.29e-08 | 180 | 119 | 9 | 35198878 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIF1A ZEB1 ESR2 AKNA PPARD RFX7 PRDM4 MEF2A ARNT HOXC10 ZNF335 DMRTA2 PAX3 CAMTA1 EMX2 SMAD4 FOXP3 | 1.42e-08 | 908 | 119 | 17 | 19274049 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 DSG2 MAP4K3 ATG13 PKP4 CILK1 CEP192 GRIP1 CCDC88A HGS RBM14 TANC1 USP54 PLEC ALDH1B1 USP15 | 3.82e-08 | 853 | 119 | 16 | 28718761 |
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 21435239 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP MTA2 TANC2 RTTN AKNA ARHGAP17 TSC2 CEP192 LYST TIAM2 WIZ MEGF8 ZNF335 USP40 SEC16A TANC1 PLEC IL4R | 4.26e-08 | 1105 | 119 | 18 | 35748872 |
| Pubmed | 8.83e-08 | 225 | 119 | 9 | 12168954 | ||
| Pubmed | DAB2IP LEMD3 DUSP1 TMEM51 PKP4 TRIOBP SMPD4 CEP192 CCDC88A WIZ HGS YLPM1 SEC16A TANC1 TNS1 NUP153 GAB1 | 1.13e-07 | 1049 | 119 | 17 | 27880917 | |
| Pubmed | DAB2IP TANC2 ZEB1 PKP4 WDR81 TRIOBP TSC2 ZNF462 CCDC88A WIZ YLPM1 SEC16A PAK3 QSER1 TNS1 NUP153 | 1.98e-07 | 963 | 119 | 16 | 28671696 | |
| Pubmed | 3.31e-07 | 263 | 119 | 9 | 34702444 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.88e-07 | 351 | 119 | 10 | 38297188 | |
| Pubmed | Graded expression of Zfp462 in the embryonic mouse cerebral cortex. | 3.89e-07 | 5 | 119 | 3 | 17207666 | |
| Pubmed | LEMD3 HIPK1 CILK1 PPARD MORC4 PRDM4 PIAS1 GRIP1 ARNT YLPM1 PLEC SMAD4 | 9.45e-07 | 591 | 119 | 12 | 15231748 | |
| Pubmed | HIF modulation of Wnt signaling regulates skeletal myogenesis in vivo. | 1.35e-06 | 7 | 119 | 3 | 26153230 | |
| Pubmed | LEMD3 ARHGAP17 SMPD4 HMCES CCDC88A TMTC3 HGS YLPM1 SEC16A TANC1 QSER1 USP54 USP15 | 1.47e-06 | 733 | 119 | 13 | 34672954 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX HDAC5 RB1 HIPK1 SMPD4 SNX33 MEF2A ARNT WIZ PLA2G4A PAX3 QSER1 SMAD4 FOXP3 | 1.48e-06 | 857 | 119 | 14 | 25609649 |
| Pubmed | 1.54e-06 | 103 | 119 | 6 | 21706016 | ||
| Pubmed | ZEB1 HDAC5 RB1 CEP192 MORC4 RFX7 FIGN PIAS1 MEF2A ZNF462 LIPT1 ARNT WIZ HGS YLPM1 SEC16A QSER1 USP54 | 1.80e-06 | 1429 | 119 | 18 | 35140242 | |
| Pubmed | 3.33e-06 | 446 | 119 | 10 | 24255178 | ||
| Pubmed | 4.50e-06 | 191 | 119 | 7 | 31177093 | ||
| Pubmed | AKAP6 DAB2IP SETX MAP4K3 ATG13 ALS2 CEP192 TIAM2 SEC16A CIPC QSER1 PLEC CAMTA1 TNS1 NUP153 | 4.65e-06 | 1084 | 119 | 15 | 11544199 | |
| Pubmed | 5.60e-06 | 371 | 119 | 9 | 25241761 | ||
| Pubmed | MTA2 HIF1A PPARD CBL PRDM4 PIAS1 MEF2A ZNF462 ARNT HOXC10 PAX3 EMX2 | 6.11e-06 | 709 | 119 | 12 | 22988430 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | MTA2 HIF1A HDAC5 RB1 ESR2 PPARD PRDM4 ARNT RBM14 PAX3 IKBKB EMX2 SMAD4 | 1.02e-05 | 877 | 119 | 13 | 20211142 |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33835424 | ||
| Pubmed | A HIF-1α-driven feed-forward loop augments HIF signalling in Hep3B cells by upregulation of ARNT. | 1.16e-05 | 2 | 119 | 2 | 27362802 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15987772 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22484155 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 14680833 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11606485 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10777486 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9159130 | ||
| Pubmed | The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia. | 1.16e-05 | 2 | 119 | 2 | 10873592 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25592037 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15031145 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22699503 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12391259 | ||
| Pubmed | Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5. | 1.16e-05 | 2 | 119 | 2 | 32485181 | |
| Pubmed | Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer. | 1.16e-05 | 2 | 119 | 2 | 33431674 | |
| Pubmed | [Hypoxia and its simulant CoCl(2) down-regulates Foxp3 expression independent from HIF-1alpha]. | 1.16e-05 | 2 | 119 | 2 | 19549358 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28484714 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10085255 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33419772 | ||
| Pubmed | Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. | 1.16e-05 | 2 | 119 | 2 | 8663540 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18432192 | ||
| Pubmed | Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta. | 1.16e-05 | 2 | 119 | 2 | 19303878 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11914036 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23443660 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23541582 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15028714 | ||
| Pubmed | Regulation of hypoxia-inducible factor 1 by glucose availability under hypoxic conditions. | 1.16e-05 | 2 | 119 | 2 | 18762723 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21873554 | ||
| Pubmed | Optical analysis of the HIF-1 complex in living cells by FRET and FRAP. | 1.16e-05 | 2 | 119 | 2 | 17197389 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12626519 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21068316 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26057751 | ||
| Pubmed | mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha. | 1.16e-05 | 2 | 119 | 2 | 19109240 | |
| Pubmed | Effect of HIF1α on Foxp3 expression in CD4+ CD25- T lymphocytes. | 1.16e-05 | 2 | 119 | 2 | 24931519 | |
| Pubmed | Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. | 1.16e-05 | 2 | 119 | 2 | 20440072 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9368100 | ||
| Pubmed | Purification and characterization of hypoxia-inducible factor 1. | 1.16e-05 | 2 | 119 | 2 | 7836384 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 37664931 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 7539918 | ||
| Pubmed | Development of inhibitors of the PAS-B domain of the HIF-2α transcription factor. | 1.16e-05 | 2 | 119 | 2 | 23363003 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 14638687 | ||
| Pubmed | HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity. | 1.16e-05 | 2 | 119 | 2 | 25904334 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18198354 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17213817 | ||
| Pubmed | Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha. | 1.16e-05 | 2 | 119 | 2 | 8702901 | |
| Pubmed | Overexpression of ERβ is sufficient to inhibit hypoxia-inducible factor-1 transactivation. | 1.16e-05 | 2 | 119 | 2 | 24938129 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28583190 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15479785 | ||
| Pubmed | Expression of hypoxia-inducible factor 1: mechanisms and consequences. | 1.16e-05 | 2 | 119 | 2 | 10605934 | |
| Pubmed | Site-directed mutagenesis studies of the hypoxia-inducible factor-1alpha DNA-binding domain. | 1.16e-05 | 2 | 119 | 2 | 12393189 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24201117 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24127318 | ||
| Pubmed | Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1. | 1.16e-05 | 2 | 119 | 2 | 16861921 | |
| Pubmed | Bacterially produced human HIF-1alpha is competent for heterodimerization and specific DNA-binding. | 1.16e-05 | 2 | 119 | 2 | 15850782 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26066603 | ||
| Pubmed | DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1. | 1.16e-05 | 2 | 119 | 2 | 25043300 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26010887 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26587829 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8662957 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11829741 | ||
| Pubmed | Role of HIF-1α in Alcohol-Mediated Multiple Organ Dysfunction. | 1.16e-05 | 2 | 119 | 2 | 30544759 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22262832 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20932347 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP MTA2 TANC2 HDAC5 RB1 MYO19 CILK1 TSC2 SNX33 CCDC88A SEC16A RBM14 QSER1 PLEC USP15 FYB2 | 1.16e-05 | 1321 | 119 | 16 | 27173435 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.81e-05 | 430 | 119 | 9 | 35044719 | |
| Pubmed | 2.11e-05 | 335 | 119 | 8 | 15741177 | ||
| Pubmed | 2.12e-05 | 16 | 119 | 3 | 11256068 | ||
| Pubmed | Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15. | 2.12e-05 | 16 | 119 | 3 | 24984263 | |
| Pubmed | MTA2 HIF1A ZEB1 ESR2 PPARD PRDM4 PIAS1 MEF2A ZNF462 ARNT WIZ SMAD4 | 2.23e-05 | 808 | 119 | 12 | 20412781 | |
| Pubmed | 2.50e-05 | 100 | 119 | 5 | 26073538 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 2.58e-05 | 565 | 119 | 10 | 25468996 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.92e-05 | 457 | 119 | 9 | 32344865 | |
| Interaction | YWHAH interactions | DAB2IP TANC2 DOCK4 SETX HDAC5 DSG2 ATG13 ESR2 ARHGAP17 ALS2 TSC2 CEP192 SNX33 RFX7 CBL LYST GRIP1 CCDC88A MEGF8 SEC16A RBM14 TANC1 USP54 PLEC ALDH1B1 GAB1 | 2.49e-10 | 1102 | 112 | 26 | int:YWHAH |
| Interaction | SFN interactions | TANC2 HIF1A HDAC5 DSG2 ATG13 PLEKHF2 ESR2 TSC2 CEP192 CBL PIAS1 LYST GRIP1 ARNT CCDC88A RBM14 TANC1 USP54 PLEC GAB1 | 1.33e-09 | 692 | 112 | 20 | int:SFN |
| Interaction | YWHAG interactions | DAB2IP TANC2 DOCK4 HDAC5 DSG2 MAP4K3 ATG13 ESR2 ARHGAP17 ALS2 TSC2 CEP192 SNX33 RFX7 CBL PIAS1 LYST GRIP1 CCDC88A HOXC10 SEC16A RBM14 TANC1 USP54 ALDH1B1 GAB1 | 3.48e-09 | 1248 | 112 | 26 | int:YWHAG |
| Interaction | EPHA2 interactions | DAB2IP HIF1A DSG2 LEMD3 MAP4K3 TMEM51 PKP4 TRIOBP PLEKHA6 CBL RYK GRIP1 ARNT CCDC88A SEMA6D HGS SEC16A USP54 GAB1 | 1.54e-08 | 719 | 112 | 19 | int:EPHA2 |
| Interaction | SMAD3 interactions | MTA2 HIF1A ZEB1 HDAC5 LEMD3 ESR2 TSC2 CBL PRDM4 GRIP1 HGS RBM14 USP15 NUP153 SMAD4 | 2.69e-08 | 447 | 112 | 15 | int:SMAD3 |
| Interaction | YWHAB interactions | DAB2IP TANC2 DOCK4 HDAC5 DSG2 ATG13 PLEKHF2 ESR2 ALS2 TSC2 CEP192 RFX7 CBL LYST GRIP1 CCDC88A HGS RBM14 TANC1 USP54 IKBKB GAB1 | 3.41e-08 | 1014 | 112 | 22 | int:YWHAB |
| Interaction | DTX2 interactions | DSG2 LEMD3 PLEKHF2 PKP4 RFX7 PIAS1 HGS YLPM1 SEC16A RBM14 USP54 NUP153 | 3.11e-07 | 330 | 112 | 12 | int:DTX2 |
| Interaction | MAPK14 interactions | RB1 ATG13 MYO19 DUSP1 CBL MEF2A ARNT HOXC10 PAK3 PLA2G4A IKBKB NUP153 | 6.36e-07 | 353 | 112 | 12 | int:MAPK14 |
| Interaction | CTNNB1 interactions | MTA2 TANC2 HIF1A DSG2 ESR2 PKP4 PLEKHA6 CBL RYK GRIP1 ARNT CCDC88A SEC16A RBM14 TANC1 PAX3 USP54 IKBKB USP15 SMAD4 | 6.61e-07 | 1009 | 112 | 20 | int:CTNNB1 |
| Interaction | PARD3 interactions | DSG2 ESR2 PKP4 ARHGAP17 PLEKHA6 TIAM2 CCDC88A TANC1 USP54 GAB1 SMAD4 | 8.58e-07 | 298 | 112 | 11 | int:PARD3 |
| Interaction | HDAC1 interactions | MTA2 HIF1A ZEB1 HDAC5 RB1 ESR2 PPARD MORC4 PRDM4 MEF2A GRIP1 ARNT WIZ PAX3 PLEC ALDH1B1 USP15 SMAD4 DNMT3B FOXP3 | 2.79e-06 | 1108 | 112 | 20 | int:HDAC1 |
| Interaction | YWHAZ interactions | DAB2IP TANC2 HDAC5 DSG2 ATG13 ESR2 ALS2 TSC2 CEP192 SNX33 CBL PIAS1 LYST GRIP1 CCDC88A RBM14 TANC1 USP54 PLEC ALDH1B1 TNS1 GAB1 | 2.99e-06 | 1319 | 112 | 22 | int:YWHAZ |
| Interaction | OCLN interactions | DAB2IP DSG2 MAP4K3 ESR2 TMEM51 PKP4 CCDC88A HGS USP40 TANC1 USP54 GAB1 SMAD4 | 4.19e-06 | 500 | 112 | 13 | int:OCLN |
| Interaction | LATS2 interactions | 4.92e-06 | 289 | 112 | 10 | int:LATS2 | |
| Interaction | RAC1 interactions | DAB2IP DOCK4 DSG2 LEMD3 MYO19 ESR2 TMEM51 PKP4 TRIOBP BIRC2 ARHGAP17 ARNT CCDC88A SEMA6D TMTC3 PAK3 TANC1 QSER1 GAB1 | 5.92e-06 | 1063 | 112 | 19 | int:RAC1 |
| Interaction | PPP1CA interactions | TANC2 HDAC5 RB1 MYO19 ESR2 TRIOBP TSC2 CEP192 PIAS1 MEF2A ARNT YLPM1 UBXN2A IKBKB NUP153 | 7.17e-06 | 696 | 112 | 15 | int:PPP1CA |
| Interaction | FGFR2 interactions | 7.60e-06 | 239 | 112 | 9 | int:FGFR2 | |
| Interaction | AR interactions | HIF1A WIPI1 DSG2 RB1 MORC4 PIAS1 MEF2A GRIP1 ZNF462 ARNT WIZ YLPM1 SEC16A RBM14 QSER1 USP54 TNS1 SMAD4 | 8.76e-06 | 992 | 112 | 18 | int:AR |
| Interaction | C11orf52 interactions | 9.35e-06 | 311 | 112 | 10 | int:C11orf52 | |
| Interaction | HDAC3 interactions | 9.89e-06 | 313 | 112 | 10 | int:HDAC3 | |
| Interaction | SMAD2 interactions | MTA2 ZEB1 LEMD3 ESR2 TSC2 MEF2A HGS RBM14 USP15 NUP153 SMAD4 | 1.00e-05 | 385 | 112 | 11 | int:SMAD2 |
| Interaction | MAPK1 interactions | HIF1A RB1 DUSP1 ESR2 CILK1 TSC2 RYK TUBGCP3 SEC16A PLA2G4A NUP153 GAB1 SMAD4 | 1.02e-05 | 543 | 112 | 13 | int:MAPK1 |
| Interaction | YWHAQ interactions | DAB2IP TANC2 HDAC5 DSG2 ESR2 ALS2 TSC2 CEP192 RFX7 CBL LYST GRIP1 CCDC88A TUBGCP3 RBM14 TANC1 USP54 PLEC GAB1 | 1.21e-05 | 1118 | 112 | 19 | int:YWHAQ |
| Interaction | NANOG interactions | MTA2 HIF1A LEMD3 ZNF462 ARNT WIZ TUBGCP3 SEC16A RBM14 QSER1 SMAD4 DNMT3B | 1.52e-05 | 481 | 112 | 12 | int:NANOG |
| Interaction | UBE2I interactions | HIF1A SETX HDAC5 RB1 HIPK1 PIAS1 MEF2A GRIP1 ARNT HGS RBM14 NUP153 SMAD4 DNMT3B | 1.60e-05 | 654 | 112 | 14 | int:UBE2I |
| Interaction | RELA interactions | MTA2 HIF1A PPARD PIAS1 ARNT SEC16A RBM14 PLA2G4A IKBKB SMAD4 DNMT3B FOXP3 | 1.65e-05 | 485 | 112 | 12 | int:RELA |
| Interaction | KDM1A interactions | MTA2 ZEB1 HDAC5 RB1 ESR2 BIRC2 PPARD MORC4 ZNF462 CCDC88A WIZ SEC16A PLEC TSACC USP15 SMAD4 FOXP3 | 1.70e-05 | 941 | 112 | 17 | int:KDM1A |
| Interaction | RHOD interactions | DSG2 LEMD3 MYO19 ESR2 TMEM51 PKP4 TRIOBP SMPD4 CCDC88A SEMA6D TMTC3 GAB1 SMAD4 | 1.76e-05 | 572 | 112 | 13 | int:RHOD |
| Interaction | CCAR2 interactions | HIF1A HDAC5 DUSP1 ZNF335 SEC16A RBM14 PLEC IKBKB USP15 FOXP3 | 1.87e-05 | 337 | 112 | 10 | int:CCAR2 |
| Interaction | NES interactions | 2.26e-05 | 152 | 112 | 7 | int:NES | |
| Interaction | MAPK3 interactions | HIF1A RB1 DUSP1 ESR2 TSC2 RFX7 RYK TUBGCP3 PLA2G4A NUP153 GAB1 | 2.30e-05 | 421 | 112 | 11 | int:MAPK3 |
| Interaction | WWTR1 interactions | 2.35e-05 | 422 | 112 | 11 | int:WWTR1 | |
| Interaction | GSK3B interactions | HIF1A DSG2 TRIOBP BIRC2 TSC2 CEP192 PIAS1 HMCES CCDC88A SEC16A TANC1 TRAK2 PLEC GAB1 SMAD4 FOXP3 | 2.42e-05 | 868 | 112 | 16 | int:GSK3B |
| Interaction | SUMO1 interactions | 3.24e-05 | 287 | 112 | 9 | int:SUMO1 | |
| Interaction | NRAS interactions | DAB2IP DSG2 LEMD3 MAP4K3 ESR2 TMEM51 PKP4 ARHGAP17 CBL PRDM4 CCDC88A TANC1 GAB1 SMAD4 | 3.33e-05 | 699 | 112 | 14 | int:NRAS |
| Interaction | RHBDF2 interactions | 4.29e-05 | 168 | 112 | 7 | int:RHBDF2 | |
| Interaction | NRIP1 interactions | 4.63e-05 | 170 | 112 | 7 | int:NRIP1 | |
| Interaction | NXF1 interactions | ESR2 PKP4 WDR81 BIRC2 ARHGAP17 CEP192 MORC4 PIAS1 RYK HOXC10 WIZ MEGF8 TUBGCP3 HGS YLPM1 PLA2G4A CIPC TANC1 USP15 NUP153 | 4.73e-05 | 1345 | 112 | 20 | int:NXF1 |
| Interaction | FGFR4 interactions | 4.94e-05 | 458 | 112 | 11 | int:FGFR4 | |
| Interaction | RHOJ interactions | DAB2IP DSG2 LEMD3 TMEM51 PKP4 CCDC88A TMTC3 HGS PAK3 TANC1 IL4R GAB1 SMAD4 | 5.03e-05 | 633 | 112 | 13 | int:RHOJ |
| Interaction | RHOB interactions | DAB2IP DSG2 ESR2 PKP4 TRIOBP ARHGAP17 TSC2 PIAS1 TIAM2 CCDC88A SEMA6D TMTC3 HGS ALDH1B1 GAB1 | 6.36e-05 | 840 | 112 | 15 | int:RHOB |
| Interaction | FOXO3 interactions | 6.75e-05 | 124 | 112 | 6 | int:FOXO3 | |
| Interaction | FLOT1 interactions | 6.85e-05 | 475 | 112 | 11 | int:FLOT1 | |
| Interaction | RUNX2 interactions | 7.38e-05 | 126 | 112 | 6 | int:RUNX2 | |
| Interaction | SMAD7 interactions | 7.71e-05 | 127 | 112 | 6 | int:SMAD7 | |
| Interaction | MAD2L1 interactions | 8.30e-05 | 252 | 112 | 8 | int:MAD2L1 | |
| Interaction | CELA2A interactions | 8.88e-05 | 16 | 112 | 3 | int:CELA2A | |
| Interaction | ZYX interactions | 9.29e-05 | 329 | 112 | 9 | int:ZYX | |
| Interaction | RHOF interactions | TANC2 DSG2 LEMD3 ESR2 TMEM51 PKP4 TRIOBP CCDC88A SEMA6D TMTC3 TANC1 QSER1 GAB1 | 9.34e-05 | 673 | 112 | 13 | int:RHOF |
| Interaction | NR0B2 interactions | 9.96e-05 | 83 | 112 | 5 | int:NR0B2 | |
| Interaction | MYOD1 interactions | 1.06e-04 | 194 | 112 | 7 | int:MYOD1 | |
| Interaction | IQGAP1 interactions | HIF1A DSG2 MYO19 TRIOBP CBL PIAS1 BMX TUBGCP3 SEC16A PLEC USP15 FOXP3 | 1.11e-04 | 591 | 112 | 12 | int:IQGAP1 |
| Interaction | GATA2 interactions | 1.24e-04 | 199 | 112 | 7 | int:GATA2 | |
| Interaction | RNF43 interactions | LEMD3 SMPD4 CCDC88A HGS SEC16A RBM14 TANC1 USP54 USP15 NUP153 | 1.36e-04 | 427 | 112 | 10 | int:RNF43 |
| Interaction | FEV interactions | 1.41e-04 | 203 | 112 | 7 | int:FEV | |
| Interaction | HNF4A interactions | 1.52e-04 | 275 | 112 | 8 | int:HNF4A | |
| Interaction | PIAS1 interactions | 1.58e-04 | 353 | 112 | 9 | int:PIAS1 | |
| Interaction | SGCE interactions | 1.78e-04 | 20 | 112 | 3 | int:SGCE | |
| Interaction | SYNE3 interactions | 1.86e-04 | 444 | 112 | 10 | int:SYNE3 | |
| Interaction | SHC1 interactions | 1.91e-04 | 362 | 112 | 9 | int:SHC1 | |
| Interaction | XRCC6 interactions | MTA2 HIF1A ZEB1 HDAC5 ATG13 CBL PIAS1 RYK ARNT WIZ YLPM1 RBM14 EMX2 NUP153 SMAD4 | 1.91e-04 | 928 | 112 | 15 | int:XRCC6 |
| Interaction | NCOR1 interactions | 1.95e-04 | 363 | 112 | 9 | int:NCOR1 | |
| Interaction | RHOBTB3 interactions | 1.98e-04 | 96 | 112 | 5 | int:RHOBTB3 | |
| Interaction | STX6 interactions | 2.00e-04 | 448 | 112 | 10 | int:STX6 | |
| Interaction | ZFPL1 interactions | 2.00e-04 | 448 | 112 | 10 | int:ZFPL1 | |
| Interaction | LTK interactions | 2.07e-04 | 152 | 112 | 6 | int:LTK | |
| Interaction | TFCP2L1 interactions | 2.29e-04 | 99 | 112 | 5 | int:TFCP2L1 | |
| Interaction | ATG12 interactions | 2.50e-04 | 296 | 112 | 8 | int:ATG12 | |
| Interaction | DYRK1A interactions | RB1 ESR2 TRIOBP TSC2 RFX7 PRDM4 SEC16A ASTN2 TANC1 USP54 NUP153 | 2.55e-04 | 552 | 112 | 11 | int:DYRK1A |
| Interaction | LCK interactions | 2.60e-04 | 463 | 112 | 10 | int:LCK | |
| Interaction | EGLN3 interactions | HIF1A SETX DSG2 LEMD3 BIRC2 CEP192 CBL ARNT CCDC88A TUBGCP3 SEC16A PAX3 USP54 ALDH1B1 IKBKB USP15 NUP153 GAB1 | 2.77e-04 | 1296 | 112 | 18 | int:EGLN3 |
| Interaction | STYK1 interactions | 2.82e-04 | 161 | 112 | 6 | int:STYK1 | |
| Interaction | MYH9 interactions | MTA2 HDAC5 DSG2 MYO19 ESR2 TRIOBP CBL PIAS1 ARNT SEC16A PLEC ALDH1B1 USP15 | 2.85e-04 | 754 | 112 | 13 | int:MYH9 |
| Interaction | CBFB interactions | 2.88e-04 | 104 | 112 | 5 | int:CBFB | |
| Interaction | TSG101 interactions | 2.93e-04 | 303 | 112 | 8 | int:TSG101 | |
| Interaction | MYO18A interactions | 2.93e-04 | 303 | 112 | 8 | int:MYO18A | |
| Interaction | HDAC2 interactions | MTA2 HIF1A ZEB1 RB1 ESR2 PPARD PRDM4 WIZ TUBGCP3 RBM14 USP15 SMAD4 DNMT3B FOXP3 | 3.13e-04 | 865 | 112 | 14 | int:HDAC2 |
| Interaction | DCP1A interactions | 3.32e-04 | 166 | 112 | 6 | int:DCP1A | |
| Interaction | RAB35 interactions | DAB2IP DSG2 LEMD3 ESR2 TMEM51 PKP4 SMPD4 CCDC88A RBM14 TANC1 GAB1 | 3.50e-04 | 573 | 112 | 11 | int:RAB35 |
| Interaction | EPHA8 interactions | 3.66e-04 | 169 | 112 | 6 | int:EPHA8 | |
| Interaction | EHMT2 interactions | 3.79e-04 | 315 | 112 | 8 | int:EHMT2 | |
| Interaction | EGR2 interactions | 3.89e-04 | 171 | 112 | 6 | int:EGR2 | |
| Interaction | ITK interactions | 3.93e-04 | 62 | 112 | 4 | int:ITK | |
| Interaction | GJA1 interactions | DSG2 LEMD3 TMEM51 PKP4 SMPD4 THSD1 CCDC88A HGS SEC16A TANC1 GAB1 | 4.05e-04 | 583 | 112 | 11 | int:GJA1 |
| Interaction | SMAD1 interactions | 4.21e-04 | 243 | 112 | 7 | int:SMAD1 | |
| Interaction | SIGLECL1 interactions | 4.22e-04 | 113 | 112 | 5 | int:SIGLECL1 | |
| Interaction | BCR interactions | 4.31e-04 | 244 | 112 | 7 | int:BCR | |
| Interaction | ERBB2 interactions | 4.41e-04 | 589 | 112 | 11 | int:ERBB2 | |
| Interaction | TOP3B interactions | DAB2IP MTA2 TANC2 RTTN AKNA ARHGAP17 TSC2 CEP192 LYST TIAM2 WIZ MEGF8 ZNF335 USP40 SEC16A RBM14 TANC1 PLEC IL4R | 4.54e-04 | 1470 | 112 | 19 | int:TOP3B |
| Interaction | PTPRK interactions | 4.67e-04 | 177 | 112 | 6 | int:PTPRK | |
| Interaction | GNB2 interactions | 4.92e-04 | 502 | 112 | 10 | int:GNB2 | |
| Interaction | VEGFA interactions | 5.00e-04 | 66 | 112 | 4 | int:VEGFA | |
| Interaction | TAX1BP3 interactions | 5.00e-04 | 66 | 112 | 4 | int:TAX1BP3 | |
| Interaction | DDB1 interactions | MTA2 HIF1A HDAC5 ESR2 WDR81 CBL MEF2A ARNT USP40 ALDH1B1 USP15 DNMT3B | 5.00e-04 | 697 | 112 | 12 | int:DDB1 |
| Interaction | SMYD2 interactions | 5.29e-04 | 67 | 112 | 4 | int:SMYD2 | |
| Interaction | SKIL interactions | 5.35e-04 | 119 | 112 | 5 | int:SKIL | |
| Interaction | CRX interactions | 5.48e-04 | 254 | 112 | 7 | int:CRX | |
| Interaction | PHLPP1 interactions | 5.48e-04 | 333 | 112 | 8 | int:PHLPP1 | |
| Interaction | FTCD interactions | 5.50e-04 | 29 | 112 | 3 | int:FTCD | |
| Interaction | YWHAE interactions | DAB2IP MTA2 TANC2 HDAC5 ESR2 ALS2 TSC2 SNX33 CBL LYST GRIP1 CCDC88A RBM14 TANC1 USP54 ALDH1B1 GAB1 | 5.59e-04 | 1256 | 112 | 17 | int:YWHAE |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.77e-04 | 206 | 87 | 6 | 682 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 8.06e-04 | 9 | 87 | 2 | 1230 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 5.37e-06 | 362 | 117 | 10 | M39176 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 DOCK4 WIPI1 HDAC5 ATG13 TMEM51 PKP4 RTTN CILK1 CEP192 SEMA6D YLPM1 PAK3 PLEC TNS1 GAB1 DNMT3B | 8.04e-06 | 1102 | 117 | 17 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 DOCK4 WIPI1 HDAC5 ATG13 TMEM51 PKP4 RTTN CILK1 CEP192 SEMA6D YLPM1 PAK3 PLEC TNS1 GAB1 DNMT3B | 1.04e-05 | 1124 | 117 | 17 | MM1070 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.27e-05 | 240 | 117 | 8 | M39236 | |
| Coexpression | GSE29618_BCELL_VS_PDC_UP | 2.91e-05 | 196 | 117 | 7 | M4940 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 3.21e-05 | 199 | 117 | 7 | M6443 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 3.31e-05 | 200 | 117 | 7 | M7781 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN | 3.31e-05 | 200 | 117 | 7 | M6585 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 9.02e-05 | 162 | 117 | 6 | M1960 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | DAB2IP DSG2 RTTN WDR81 SMPD4 SFR1 CBL MEF2A ZNF462 ZNF335 CIPC PLEC IL4R | 1.02e-04 | 843 | 117 | 13 | M2356 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 HIF1A ZEB1 SETX RB1 DUSP1 PKP4 MEF2A RYK TUBGCP3 USP15 NUP153 SMAD4 | 1.19e-04 | 856 | 117 | 13 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 TANC2 DOCK4 TSC2 PLEKHA6 RFX7 ZBED10P LYST EBF2 GRIP1 ZNF462 CCDC88A SEMA6D PAK3 CAMTA1 | 1.23e-04 | 1106 | 117 | 15 | M39071 |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 1.34e-04 | 174 | 117 | 6 | MM836 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.35e-04 | 429 | 117 | 9 | M29 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.42e-04 | 432 | 117 | 9 | M41149 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 1.59e-04 | 257 | 117 | 7 | M13867 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | 1.60e-04 | 344 | 117 | 8 | M2239 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | ROBO4 DUSP1 BIRC2 PPARD THSD1 ZBED10P CCDC88A HGS PLA2G4A TANC1 CAPS2 DNMT3B | 1.70e-04 | 768 | 117 | 12 | M6444 |
| Coexpression | GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP | 2.62e-04 | 197 | 117 | 6 | M5363 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 2.62e-04 | 197 | 117 | 6 | M9569 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 2.69e-04 | 198 | 117 | 6 | M7610 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 2.76e-04 | 199 | 117 | 6 | M9418 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP | 2.76e-04 | 199 | 117 | 6 | M5709 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 2.84e-04 | 200 | 117 | 6 | M9459 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 2.84e-04 | 200 | 117 | 6 | M6477 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP | 2.84e-04 | 200 | 117 | 6 | M5815 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP | 2.84e-04 | 200 | 117 | 6 | M4524 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP | 2.84e-04 | 200 | 117 | 6 | M4568 | |
| Coexpression | GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN | 2.84e-04 | 200 | 117 | 6 | M9071 | |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_DN | 2.84e-04 | 200 | 117 | 6 | M8471 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP | 2.84e-04 | 200 | 117 | 6 | M7159 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 2.84e-04 | 200 | 117 | 6 | M7495 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP | 2.84e-04 | 200 | 117 | 6 | M9994 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN | 2.84e-04 | 200 | 117 | 6 | M4318 | |
| Coexpression | GU_PDEF_TARGETS_UP | 2.91e-04 | 71 | 117 | 4 | M3955 | |
| Coexpression | PEREZ_TP53_TARGETS | DAB2IP DOCK4 HDAC5 TSC2 MEF2A UBXN2A CIPC TRAK2 CAMTA1 EMX2 USP15 TNS1 FYB2 GAB1 DNMT3B | 2.98e-04 | 1201 | 117 | 15 | M4391 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TANC2 DSG2 CILK1 RFX7 FIGN PIAS1 TIAM2 ZNF462 CCDC88A TMTC3 ST8SIA6 YLPM1 RBM14 PAK3 PAX3 CAMTA1 | 1.55e-05 | 850 | 116 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-07 | 175 | 119 | 7 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.64e-07 | 192 | 119 | 7 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.14e-06 | 200 | 119 | 7 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.14e-06 | 200 | 119 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.14e-06 | 200 | 119 | 7 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.14e-06 | 200 | 119 | 7 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-06 | 150 | 119 | 6 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-06 | 167 | 119 | 6 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-06 | 175 | 119 | 6 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-06 | 175 | 119 | 6 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 184 | 119 | 6 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 186 | 119 | 6 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 187 | 119 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 188 | 119 | 6 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.26e-05 | 191 | 119 | 6 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-05 | 196 | 119 | 6 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 132 | 119 | 5 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 132 | 119 | 5 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.83e-05 | 159 | 119 | 5 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 165 | 119 | 5 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 165 | 119 | 5 | 6a621b300442c52adfc15b61d3a6d3a3cb00099f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-05 | 167 | 119 | 5 | edc5f04584b44f99ff9a62bbe0dab6fc044fb334 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.37e-05 | 170 | 119 | 5 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 9.37e-05 | 170 | 119 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.02e-04 | 173 | 119 | 5 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 173 | 119 | 5 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 174 | 119 | 5 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-04 | 174 | 119 | 5 | 66df78280f657978c4a568010ae7d7943869af90 | |
| ToppCell | CTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 1.04e-04 | 174 | 119 | 5 | ff4315e9fad198cc323fc987deb8652da137cf98 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 176 | 119 | 5 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 178 | 119 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.26e-04 | 181 | 119 | 5 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 182 | 119 | 5 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 1.32e-04 | 183 | 119 | 5 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 1.32e-04 | 183 | 119 | 5 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 184 | 119 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Aerocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 185 | 119 | 5 | 7b3d30a54bec66ca6b0209c86448f4fff97ed75c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 185 | 119 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 185 | 119 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 185 | 119 | 5 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 186 | 119 | 5 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 186 | 119 | 5 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 186 | 119 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 1.46e-04 | 187 | 119 | 5 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-04 | 188 | 119 | 5 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 189 | 119 | 5 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 189 | 119 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.54e-04 | 189 | 119 | 5 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 1.54e-04 | 189 | 119 | 5 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 189 | 119 | 5 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.54e-04 | 189 | 119 | 5 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 190 | 119 | 5 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 190 | 119 | 5 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 190 | 119 | 5 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | BLOOD--(2)_B_cell-(2)_Naive_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.58e-04 | 190 | 119 | 5 | bde288cea27bbdc3ca05737a00fe30a0103a4c74 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 190 | 119 | 5 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Early_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.65e-04 | 192 | 119 | 5 | 4986ef70a665fdfa1df86f7f8a15117487eae159 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-04 | 193 | 119 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-04 | 193 | 119 | 5 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 193 | 119 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.70e-04 | 193 | 119 | 5 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.74e-04 | 194 | 119 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 194 | 119 | 5 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 119 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 194 | 119 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 119 | 5 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 194 | 119 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | ILEUM-inflamed-(2)_B_cell-(2)_Naive_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.74e-04 | 194 | 119 | 5 | a89e67a40382600739be92e395bf47dd44aa4122 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.78e-04 | 195 | 119 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.78e-04 | 195 | 119 | 5 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-04 | 196 | 119 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 196 | 119 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-04 | 196 | 119 | 5 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.82e-04 | 196 | 119 | 5 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 196 | 119 | 5 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-04 | 196 | 119 | 5 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-04 | 197 | 119 | 5 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 197 | 119 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.86e-04 | 197 | 119 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-04 | 197 | 119 | 5 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-04 | 197 | 119 | 5 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.86e-04 | 197 | 119 | 5 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.91e-04 | 198 | 119 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-04 | 198 | 119 | 5 | 59214e34b077dffa989c48635fdef143f57f1320 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.85e-06 | 179 | 116 | 8 | 4184_UP | |
| Drug | Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A | 7.51e-06 | 196 | 116 | 8 | 1713_UP | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 7.79e-06 | 197 | 116 | 8 | 6078_DN | |
| Disease | Malignant neoplasm of breast | AKAP6 HIF1A ZEB1 RB1 ESR2 BIRC2 PLA2G4A ASTN2 USP54 IKBKB TNS1 GAB1 DNMT3B FOXP3 | 6.33e-05 | 1074 | 113 | 14 | C0006142 |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 8.99e-05 | 61 | 113 | 4 | DOID:3587 (is_marker_for) | |
| Disease | chronic myeloid leukemia (is_marker_for) | 1.50e-04 | 27 | 113 | 3 | DOID:8552 (is_marker_for) | |
| Disease | hippocampal volume | 1.52e-04 | 297 | 113 | 7 | EFO_0005035 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.65e-04 | 301 | 113 | 7 | DOID:684 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 3.54e-04 | 157 | 113 | 5 | DOID:9256 (is_marker_for) | |
| Disease | Pancreatic Neoplasm | 6.03e-04 | 100 | 113 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 6.49e-04 | 102 | 113 | 4 | C0346647 | |
| Disease | urinary bladder cancer (is_marker_for) | 7.77e-04 | 107 | 113 | 4 | DOID:11054 (is_marker_for) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 8.04e-04 | 108 | 113 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 8.86e-04 | 49 | 113 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | prostatitis (biomarker_via_orthology) | 9.36e-04 | 12 | 113 | 2 | DOID:14654 (biomarker_via_orthology) | |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | Mammary Carcinoma, Human | 9.53e-04 | 525 | 113 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 9.53e-04 | 525 | 113 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 9.76e-04 | 527 | 113 | 8 | C1458155 | |
| Disease | cerebellar volume measurement | 1.05e-03 | 52 | 113 | 3 | EFO_0020864 | |
| Disease | Polydactyly | 1.08e-03 | 117 | 113 | 4 | C0152427 | |
| Disease | prostate cancer (is_implicated_in) | 1.08e-03 | 117 | 113 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | platelet crit | RTTN PLEKHA6 CBL PIAS1 YLPM1 UBXN2A HFM1 PLEC ALDH1B1 USP15 SMAD4 | 1.08e-03 | 952 | 113 | 11 | EFO_0007985 |
| Disease | skin melanoma (is_marker_for) | 1.10e-03 | 13 | 113 | 2 | DOID:8923 (is_marker_for) | |
| Disease | Breast Carcinoma | 1.11e-03 | 538 | 113 | 8 | C0678222 | |
| Disease | interleukin 1 receptor antagonist measurement | 1.11e-03 | 53 | 113 | 3 | EFO_0004754 | |
| Disease | cortical thickness | AKAP6 TRIOBP GRIP1 ZNF462 CCDC88A YLPM1 ASTN2 QSER1 PLEC CAMTA1 USP15 TNS1 | 1.17e-03 | 1113 | 113 | 12 | EFO_0004840 |
| Disease | Peripheral Nervous System Diseases | 1.18e-03 | 54 | 113 | 3 | C4721453 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 1.45e-03 | 58 | 113 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | renal cell carcinoma (is_marker_for) | 1.51e-03 | 128 | 113 | 4 | DOID:4450 (is_marker_for) | |
| Disease | asthma (biomarker_via_orthology) | 1.52e-03 | 59 | 113 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | acute kidney failure (biomarker_via_orthology) | 1.67e-03 | 61 | 113 | 3 | DOID:3021 (biomarker_via_orthology) | |
| Disease | Idiopathic pulmonary arterial hypertension | 1.68e-03 | 16 | 113 | 2 | C3203102 | |
| Disease | Amyotrophic lateral sclerosis | 1.90e-03 | 17 | 113 | 2 | cv:C0002736 | |
| Disease | Familial primary pulmonary hypertension | 1.90e-03 | 17 | 113 | 2 | C0340543 | |
| Disease | serum albumin measurement | 2.03e-03 | 592 | 113 | 8 | EFO_0004535 | |
| Disease | Neoplasms, Experimental | 2.10e-03 | 66 | 113 | 3 | C0027659 | |
| Disease | bipolar I disorder | 2.15e-03 | 141 | 113 | 4 | EFO_0009963 | |
| Disease | Abdominal Aortic Aneurysm | 2.29e-03 | 68 | 113 | 3 | EFO_0004214 | |
| Disease | Systemic Scleroderma | 2.38e-03 | 19 | 113 | 2 | C0036421 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 2.38e-03 | 19 | 113 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 2.38e-03 | 19 | 113 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | migraine disorder | 2.57e-03 | 357 | 113 | 6 | MONDO_0005277 | |
| Disease | Deaf Mutism | 2.64e-03 | 20 | 113 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 2.64e-03 | 20 | 113 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 2.64e-03 | 20 | 113 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 2.64e-03 | 20 | 113 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 2.64e-03 | 20 | 113 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 2.64e-03 | 20 | 113 | 2 | C0011052 | |
| Disease | breast cancer (is_implicated_in) | 2.69e-03 | 150 | 113 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | Sarcoma | 2.91e-03 | 21 | 113 | 2 | C1261473 | |
| Disease | in situ carcinoma (is_marker_for) | 2.91e-03 | 21 | 113 | 2 | DOID:8719 (is_marker_for) | |
| Disease | PR interval | 3.01e-03 | 495 | 113 | 7 | EFO_0004462 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.02e-03 | 75 | 113 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 3.10e-03 | 156 | 113 | 4 | C0376634 | |
| Disease | Paroxysmal atrial fibrillation | 3.10e-03 | 156 | 113 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.10e-03 | 156 | 113 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.10e-03 | 156 | 113 | 4 | C2585653 | |
| Disease | mean arterial pressure | 3.14e-03 | 499 | 113 | 7 | EFO_0006340 | |
| Disease | cervical squamous cell carcinoma (is_marker_for) | 3.19e-03 | 22 | 113 | 2 | DOID:3744 (is_marker_for) | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.19e-03 | 22 | 113 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Primary microcephaly | 3.19e-03 | 22 | 113 | 2 | C0431350 | |
| Disease | Autistic Disorder | 3.37e-03 | 261 | 113 | 5 | C0004352 | |
| Disease | Atrial Fibrillation | 3.39e-03 | 160 | 113 | 4 | C0004238 | |
| Disease | Endometrioma | 3.47e-03 | 161 | 113 | 4 | C0269102 | |
| Disease | Endometriosis | 3.47e-03 | 161 | 113 | 4 | C0014175 | |
| Disease | Carcinomatosis | 3.62e-03 | 163 | 113 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 3.62e-03 | 163 | 113 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 3.62e-03 | 163 | 113 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 3.62e-03 | 163 | 113 | 4 | C0205696 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.63e-03 | 80 | 113 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Carcinoma | 3.70e-03 | 164 | 113 | 4 | C0007097 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNPSAYSSTTLPAAR | 256 | Q99569 | |
| TASPGAAAYPSLTNR | 686 | P27540 | |
| PSQLSSSRLSYQPAA | 261 | O75143 | |
| IRSAYNEPLTPSSNT | 1456 | Q9Y6Y1 | |
| NNYSSSIPLTPSTSQ | 51 | Q8TF27 | |
| FSYIPLSTANLPNSS | 81 | Q9BXY5 | |
| PQSSSTPYARLAQDS | 181 | Q9UBC3 | |
| SSARNIPSYPDTQAV | 331 | Q96Q42 | |
| PPSSSTSLAQYDSNS | 206 | P51813 | |
| TARYSSAAALPSPIL | 16 | P30837 | |
| ISPRGYSSSSTPQQS | 456 | Q9HAK2 | |
| SLSSRSAFSPLQPNA | 431 | Q96SC8 | |
| LQQTLPLPYDATSST | 716 | O75129 | |
| ALLPPSQNSNTLYSS | 1251 | Q06278 | |
| SSTATPGNPALYSRA | 991 | Q8TDY8 | |
| TNILQYASTRPPTLS | 766 | P06400 | |
| TAQPATYRAQPSVSL | 231 | Q96PK6 | |
| AQPSATLAAPYRTQS | 506 | Q96PK6 | |
| LSRPEAQSLSPYTTS | 426 | O94776 | |
| SVLSNSIPPQSSTYR | 121 | Q2KHR3 | |
| SIPPQSSTYRSAQES | 126 | Q2KHR3 | |
| PSLSYSSASRAQNLP | 471 | Q2KHR3 | |
| YSSLSSNPYLLSLPS | 396 | Q8N149 | |
| YSNSLPPSAAVAASS | 406 | Q9Y2U8 | |
| LAPASTLQSSYQIPT | 1051 | Q14126 | |
| STLQYPRPSSGTLAS | 941 | Q5VWQ8 | |
| TPPSAENANSSTLYR | 236 | O75914 | |
| SRALTPPSYSTAKNS | 396 | Q5HY92 | |
| ESRPTDNPTANSNLY | 871 | Q8IVH8 | |
| SLTYLRPKSNQSPES | 256 | Q8NGE5 | |
| NSPSSYNCSQSILPL | 11 | Q92731 | |
| STLSAVPQSSYPLLA | 181 | Q9BZS1 | |
| SSSLPYPNNLNSVLA | 256 | O14920 | |
| QLPRGSPSSYTVQTA | 891 | Q96H55 | |
| SSPLRTTSSYNSLVP | 871 | Q86Z02 | |
| PSRAPSASVDSSLYN | 246 | Q13480 | |
| SSPYRDTQSRTASPN | 656 | Q16665 | |
| PYQGIRSNATASIPS | 196 | Q9Y234 | |
| SNPYATLPRASSVIS | 1796 | Q3V6T2 | |
| SSSLQQCLSPSYLPL | 2086 | Q7Z7M0 | |
| PQTLPLSYQDRSAQS | 136 | Q96CW5 | |
| PNALSYTNPGSSLVS | 151 | Q02078 | |
| SVSSALYSPAQPSLQ | 336 | Q9NXE4 | |
| SLSLTYFRPKSNNSP | 241 | Q9H208 | |
| SNPDSSSAYCLPSTR | 346 | P23760 | |
| PSLPSISRSEYLNIS | 1216 | A2PYH4 | |
| AYRSFSNSLSQSPCP | 496 | P24394 | |
| PAVNRYSSSSLSSQA | 1636 | Q8N1I0 | |
| NSALSYLQSPITTSP | 351 | P28562 | |
| SANSLKRLPSAPDYN | 271 | P57773 | |
| TPRSQAQRYLSSPSG | 986 | Q7Z591 | |
| RNPNSAGRTPNSYLT | 61 | P0C7T7 | |
| SLSSPSYRFQGILPS | 666 | Q99698 | |
| SPSLALNTYPSYLSQ | 61 | Q9NYD6 | |
| LTQPSLSAAPFAQRY | 1251 | Q8TEP8 | |
| PSSSANAIYSLAARP | 666 | P22681 | |
| IRPAALSYANSSPIN | 31 | Q04743 | |
| ALPLDSSPNQFSLYT | 351 | Q9UQL6 | |
| RPHYSQTTRSNTLPS | 961 | Q9Y3R0 | |
| LTSPLSSARLDYQPS | 11 | E5RG02 | |
| PSTQTTQYLRADTPN | 276 | P34925 | |
| SYNKSPQSNSPVLLS | 41 | Q96FZ2 | |
| TALSITNNPSALDPY | 136 | Q9UKN5 | |
| PARSDSYSQSLKSPL | 221 | Q9H8W4 | |
| LNLNTSYPLSPLSDF | 496 | P47712 | |
| DSSSSLSRNPPSYIA | 711 | Q5HYA8 | |
| PSEVPALSSASYQTN | 116 | Q86VV8 | |
| PRLPSISSKLNYTSS | 441 | Q96M34 | |
| SYTDLSRSSSPPSLL | 41 | Q03181 | |
| STLSIPPERLASYQS | 531 | Q3BBV2 | |
| STLSIPPERLASYQS | 566 | Q86T75 | |
| APSQLSAPRRYSSSL | 691 | Q68EM7 | |
| SAPRRYSSSLSPIQA | 696 | Q68EM7 | |
| QRTPYCSSSESQPLQ | 61 | Q5VWT5 | |
| PSNRASTETYSTPAL | 186 | Q13485 | |
| SPRYLQSNSSSHTRP | 36 | Q8TE76 | |
| QVSLYNSPSVASPAR | 81 | Q8WV41 | |
| YFPSSSPVNILLSSQ | 1681 | Q7Z333 | |
| SPATAVPRATNSTYL | 56 | P61647 | |
| RSQPSSSVPSSYIRN | 1476 | Q9C0D5 | |
| SPTRQTYQSTSPALS | 1476 | Q9HCD6 | |
| LAFPSTLASTPYSLQ | 531 | O95785 | |
| SRTPSLPAVDTSYIN | 506 | O75925 | |
| SANPSSPYTNSSRKQ | 31 | Q86XK3 | |
| GPTQYNLPSRATSSS | 966 | Q9H2D6 | |
| PAQSYTALFRTQTAP | 276 | Q8WZ75 | |
| GSYSSLSPNPLNSRA | 151 | Q13490 | |
| LQSSYPNSPSAASQS | 441 | Q13023 | |
| LESNSPLSPLSANYS | 276 | Q9C0C6 | |
| SAPTQTSYQRRDTPT | 466 | Q9UPZ9 | |
| SYINLQASSPPATFL | 31 | Q96A04 | |
| SNTAVNSPALSYRLS | 706 | O60296 | |
| YSSNSPASPLSSASL | 686 | Q9Y2H5 | |
| QLLRYSPTLASETSP | 196 | Q8IVF5 | |
| YASLLSSPPTESLQN | 811 | O15027 | |
| PTDPFTRYSTNISSN | 491 | C9JQI7 | |
| STLTPRQAPAYSSRT | 671 | Q9NS62 | |
| YSPSSNSTLSISPCL | 141 | Q9NYB5 | |
| SAQRNYQSSSPLPTV | 1126 | Q9HBL0 | |
| SLYSSPVNSSAPLAE | 306 | O14964 | |
| SASRTLAPTLLYSSP | 126 | Q9UIG5 | |
| YQGSQRSPPFSLATA | 206 | P68543 | |
| NPRLSISLPSYESLT | 151 | Q9NW97 | |
| STLPKISPSSLSNNY | 236 | Q9Y4E8 | |
| RVSEYSLNSPSPLQS | 111 | Q96FA7 | |
| SGSTLYPVSNIPRSN | 1081 | Q2KHR2 | |
| PNSLSYASSALSPCL | 206 | O95473 | |
| TSTASNYPDVLTRPS | 116 | P49790 | |
| SSYPISPAVSRTQLA | 4391 | Q15149 | |
| SQSYLPSSQASPSRP | 221 | P49750 | |
| SPLNLSSSRNTQGYL | 706 | P37275 | |
| LQLASANPAISSTPY | 1456 | Q96JM2 | |
| SLPQSYAATVARPSA | 376 | Q5MNZ9 | |
| AAVSPTPTRQLTFNY | 271 | Q6ZXV5 | |
| KRSNHYSLSTNSPPL | 381 | A6NGJ6 | |
| LQPSLSRQSSYTSNG | 1021 | Q8NFY4 | |
| SESSSSADPLPNSYL | 71 | Q9H4Z2 | |
| KRSNHYSLSTNSPPL | 381 | A6NI03 | |
| QSSYILSSAETPARP | 1206 | Q9NVE5 | |
| LYLESISPSSRNPAS | 1516 | Q562E7 | |
| SLRNSPTSVLPSFYQ | 311 | P49815 | |
| SPSNSSAQPSLPLYR | 1056 | Q70EL1 | |
| FLSSILPSQPDYNSS | 96 | Q9UBF9 |